TABLE 1.
Method | Conditions | [ADO]v nM |
[ADO]isf nM |
ISF/Venous Ratio |
Predicted [ADO]isf, nM |
Reference |
---|---|---|---|---|---|---|
Transudate | Rest | 30 | 180 | 6 | 73 | Decking (1988) |
Transudate | Rest | 37 | 191 | 5 | 113 | Mohrman (1990) |
Dipyridamole | 90 | 785 | 9 | 623 | ||
SAH | Rest | 9 | 80‡ | 9 | 13 | Deussen (1988) |
Epicardial disk | Rest | 4 | 280 | 70 | 6 | Tietjan (1990) |
Dipyridamole | 27 | 1,190 | 44 | 69 | ||
Epicardial disk | Rest | 17 | 154 | 9 | 35 | Headrick (1991) |
Norepinephrine | 461 | 496 | 1 | 1,071 | ||
Capillary transport | Rest | 4 | 5–12 | 1.5–4 | Wangler (1989) | |
Dipyridamole* | 44 | 191 | 4 | |||
Capillary transport | Rest | 2 | 3–7 | 1.5–3.5 | Gorman (1991) | |
Norepinephrine† | 45 | 166–324 | 4–7 |
Predicted [ADO]isf was calculated from the cited study’s flow and [ADO]v using average capillary transport parameters from Gorman et al., 1991. ISF, interstitial fluid; SAH, accumulation of S-adenosylhomocysteine. During dipyridamole it was assumed that endothelial adenosine uptake is blocked (PSecl = PSeca = 0).
Constant pressure conditions.
Values after 20 min NE infusion.
This value is for the cytosol of the myocyte, not ISF. (Reproduced from Gorman et al., 1991, with permission.)